Iowa 2023-2024 Regular Session

Iowa Senate Bill SF2122

Introduced
1/25/24  
Introduced
1/25/24  

Caption

A bill for an act relating to the prescribing, ordering, dispensing, and administering authority of pharmacists and practitioners.

Impact

If enacted, SF2122 will have significant ramifications for state laws relating to the regulation of health professionals. It provides a clear directive that any contractual restrictions against the free use of professional judgment are unenforceable. This means that practitioners can administer appropriate treatments without fear of potential disciplinary action from their employers, highlighting a shift in accountability away from employers toward practitioners' professional discretion. Such changes could lead to increased autonomy for pharmacists and other health professionals.

Summary

Senate File 2122 aims to reform the prescribing, ordering, dispensing, and administering authority for pharmacists and practitioners in Iowa. The bill specifically prohibits health-related professional boards and employers from restricting these authorities in a manner that might deter practitioners from using medications based on their professional judgment. This legislative effort seeks to ensure that practitioners can freely operate within their scope of practice without unnecessary barriers imposed by employers or boards.

Contention

The bill may spark debate among stakeholders in the healthcare system. Proponents argue that the bill fosters an environment where medical professionals can make decisions based solely on clinical judgment, potentially enhancing patient care and outcomes. However, there may be concerns from employer groups or regulatory bodies regarding the potential lack of oversight for practitioners. Critics could argue that unrestricted authority to prescribe and dispense medications might lead to improper practices or jeopardize patient safety.

Companion Bills

No companion bills found.

Previously Filed As

IA HF2205

A bill for an act relating to the prescribing, ordering, dispensing, and administering authority of pharmacists and practitioners.

IA SF117

A bill for an act relating to the prescribing, ordering, dispensing, and administering authority of pharmacists and practitioners.(See SF 313.)

IA SF313

A bill for an act relating to the prescribing, ordering, dispensing, and administering authority of pharmacists and practitioners.(Formerly SF 117.)

IA HF183

A bill for an act relating to the ordering, administering, and dispensing of point-of-care HIV-related tests and prophylaxis drugs by a pharmacist.

IA HF605

A bill for an act relating to the prescribing and dispensing of self-administered hormonal contraceptives.

IA HB112

Provides relative to the prescribing, administering, and dispensing of drugs for off-label use

IA AB346

Establishes provisions governing the prescribing, dispensing and administering of medication designed to end the life of a patient. (BDR 40-600)

IA HB855

Relating to promoting, prescribing, administering, or dispensing prescription drugs for off-label use.

IA SF336

A bill for an act relating to the ordering and dispensing of self-administered hormonal contraceptives by a pharmacist pursuant to statewide protocols.

IA HB12

Enact the Jeff, Dave, and Angie Patient Right to Try Act

Similar Bills

IA SF117

A bill for an act relating to the prescribing, ordering, dispensing, and administering authority of pharmacists and practitioners.(See SF 313.)

IA SF313

A bill for an act relating to the prescribing, ordering, dispensing, and administering authority of pharmacists and practitioners.(Formerly SF 117.)

IA HF2205

A bill for an act relating to the prescribing, ordering, dispensing, and administering authority of pharmacists and practitioners.

NC S357

Pharmacists/Collaborative Practice

MA H4014

Authorizing pharmacists to provide opioid use disorder treatment

AZ HB2291

Opioids; containers; labeling; requirements; repeal

CA AB1503

Pharmacy.

NJ S2891

Prohibits certain steering and marketing practices involving dispensing of prescription drugs and drug samples.